Lisbon 2017 Delegate Registration Programme Exhibition Virtual Exhibition Satellites OneWorld Travel Discount
escrs app advert

Coexistence of visual and cognitive impairment in elderly people in Spain

Search Title by author or title

Session Details

Session Title: Presented Poster Session: Quality of Vision/Miscellaneous

Venue: Poster Village: Pod 3

First Author: : E.Mata Diaz SPAIN

Co Author(s): :    C. Monton Gimenez   C. De Pablo Martin   J. Gomez Pavon   M. Bermejo Mata     

Abstract Details

Purpose:

To establish the prevalence of eye diseases, visual and cognitive impairment in aged people at nursing houses in Spain.

Setting:

Ophthalmology and Geriatric Departments. Hospital Central de Cruz Roja. Madrid. Spain

Methods:

Design: Observational cross-sectional study. 48 Patients were recruited between June 2016 and February 2017 from a single centre. After informed consent they underwent complete eye examination. Patients were interviewed using a brief quality of vision questionnaire (ADVF). Cognitive function was evaluated by Mini Mental State Examination (MMSE), and Yessavage Test score for depression. Main outcomes: Best corrected visual acuity in the best eye, ocular comorbidities, scores of the ADVF (visual function), scores of the MMES, and scores of Yessavage test.

Results:

48 patients (33 women/15 men) with mean age of 88 years were included. The ADVF test mean score was of 83,9 + 2,59. Visual impairment (Visual acuity < 20/40) was present in 23/48(48%) .MMES mean score was lower( 20,2) in visual impaired than in patients with good vision( 21,4).Both visual acuity and visual function are better in patients with no dementia(p=0,017). Main ocular comorbidities found were cataract (50%),macular degeneration (27%), glaucoma (14,5%) amblyopia (14,5%),other retinal pathology (10%) diabetic retinopathy (8%) and corneal pathology(4%).

Conclusions:

Visual and cognitive function impairment are strongly correlated. Patients in nursing houses have extremely high prevalence of age-related eye diseases, being this comorbidities responsible for visual impairment, present in 48%.

Financial Disclosure:

research is funded, fully or partially, by a competing company

Back to previous